Marseille-Oxford Cancer Centres Collaboration
Cancer Research UK Oxford Centre, Institut Paoli-Calmettes and Cancer Research Centre of Marseille have MOC3 bringing together complementary clinical and scientific expertise in DNA Damage Repair (DDR) . The aim of the partnership is to expedite the translation of fundamental scientific DDR expertise into the clinic by developing a series of collaborative research projects and training programmes. The group seeks bring about patient benefit by joining the expertise and infrastructures of the two sites to tackle the major clinical challenges faced by those treating cancer patients.
The first MOCCC Symposium held during October 2018 in Marseille assembled 100 scientists representing the DNA Damage Response research community, from students to clinicians and group leaders. A follow-up meeting will take place in Oxford to identify collaborative projects centred around DDR and the maintenance of genome stability in leukemia and pancreatic cancer. In 2019 MOC3 will announce the initial series of collaborative projects.
Oxford speakers at the first MOCCC symposium included Peter McHugh, Tim Humphrey, Ester Hammond, Madalena Tarsounas, David Clynes (Department of Oncology), Dragana Ahel, Fumiko Esashi (Sir William Dunn School of Pathology), David Church, Ross Chapman (Nuffield Department of Medicine), Martin Cohn, Nick Lakin (Department of Biochemistry), Andrew Blackford (Weatherall Institute of Molecular Medicine).
Speakers from the Cancer Research Centre of Marseille were Jean-Paul Borg, Christophe Lachaud, Pierre-Henri Gaillard, Bertrand Llorente, Mauro Modesti, Vincent Géli, Xavier Morelli, Emmanuelle Charaffe-Jauffret (Institut Paoli-Calmettes) and Antony Goncalves (Marseille Immunopole Norbert Vey).